TaVNS with gait training for newly diagnosed Parkinson’s patients
Official title: Association of VAgus Nerve Stimulation and Treadmill Training for GAit Rehabilitation in DE Novo Parkinson's Disease (AVANTGARDE-PD)
Run by Fondazione Policlinico Universitario Campus Bio-Medico · NCT07337226 · Data updated 2026-11-12
This trial tests whether using noninvasive taVNS during treadmill-based gait therapy helps people with a recent Parkinson’s diagnosis walk better and show brain changes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondazione Policlinico Universitario Campus Bio-Medico Academic / other |
| Locations | 1 site (Roma, RM) |
| Status | Recruiting |
| Started | February 14, 2026 |
| Main results expected | October 2027 |
| Study ends | October 2027 |
| Registry record updated | July 16, 2026 |
| Trial ID | NCT07337226 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–80 with a recent idiopathic PD diagnosis (≤6 months), able to walk 10 meters unaided, and stable on therapy for at least one month.
✕Probably not a fit
Individuals with longer-standing PD, significant cognitive impairment, or contraindications to taVNS or MRI may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind study compares active taVNS to sham stimulation during four weeks of gait-focused rehabilitation in people with idiopathic Parkinson’s disease diagnosed within the last six months. Participants receive either taVNS with conventional physical therapy or sham taVNS during each of 12 sessions, with additional assessment of gait, brain activity, and inflammatory markers. The study also examines whether taVNS paired with therapy enhances neural plasticity and movement-related brain perfusion. Outcomes are measured at baseline, immediately after the four-week program, and at a four-week follow-up. Four parallel arms evaluate the separate and combined effects of taVNS and treadmill-based training.
Why it matters
Potential benefit: If successful, taVNS paired with gait training could improve walking speed and stability and may modulate brain activity related to movement.
How similar studies have gone: Prior work suggests taVNS can influence gait and inflammatory markers in PD, supporting advancement but with mixed replication.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Idiopathic PD diagnosis within 6 months, confirmed by neurologist specialized in Parkinson's disease and movement disorders; * Ability to walking independently for at least 10 meters unassisted; * Age included between 50 and 80; * MMSE \> 24; * On stable therapy for at least 1 month prior to the experiment. Exclusion Criteria: * Clinical and radiological red flags for atypical, vascular parkinsonism or alternative diagnosis (e.g., normal pressure hydrocephalus); * Levodopa equivalent daily dose \> 300 mg; * Any contraindication for taVNS (e.g., ear lesions, auditory prosthesis) * Any contraindication for MRI (e.g., non compatible pacemakers or prosthesis, claustrophobic subjects); * Concomitant neurological, orthopedic or active medical/oncological condition that would affect participating to the study; * Attempting to other neurorehabilitation programs within 3 months.
Where it's running
-
Campus Biomedico
Roma, Rm, Italy Recruiting
Study contacts
- Principal investigator: Massimo Marano, MD, PhD — Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128 Roma, Italy
- Study coordinator: Massimo Marano, MD, PhD
- Email: m.marano@policlinicocampus.it
- Phone: +39 3333488802
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automated language analysis to help diagnose neurodegenerative diseases
A multilingual AI-powered language test is being tried to see if speech and language patterns can help differentiate Alzheimer’s, frontotemporal dementia, Lewy body dementia, and Parkinson’s from healthy aging.
-
Brain alpha-synuclein PET imaging in Parkinson's patients and healthy seniors
This open-label study tests a radioactive tracer called [18F]MK-0947 to see how it behaves in the brains of people with Parkinson's disease compared with healthy elderly volunteers.
-
Parkinson’s self-sufficiency and rehabilitation in a Czech spa setting
This intervention tests whether a Czech self-sufficiency test can be used with people with Parkinson’s disease and sees how spa-based rehabilitation affects independence, cognition, balance, and walking.
-
Imaging PD progression with [18F]AV-133 using high- and standard-resolution PET
This study tests how [18F]AV-133 PET imaging changes over 12 months in people with Parkinson's disease and a small group of healthy controls.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Sleep and adaptive DBS in Parkinson’s disease
This study tests whether adjusting adaptive deep brain stimulation during sleep can improve sleep quality and brain activity in people with Parkinson’s disease who already have DBS.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.